SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-004750
Filing Date
2018-03-07
Accepted
2018-03-07 16:52:58
Documents
83
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xene-10k_20171231.htm 10-K 3269151
2 EX-23.1 xene-ex231_10.htm EX-23.1 19862
3 EX-31.1 xene-ex311_6.htm EX-31.1 16403
4 EX-31.2 xene-ex312_9.htm EX-31.2 16375
5 EX-32.1 xene-ex321_7.htm EX-32.1 8034
6 EX-32.2 xene-ex322_8.htm EX-32.2 8058
7 GRAPHIC g2018030720571315145501.jpg GRAPHIC 45789
8 GRAPHIC g2018030720572545545502.jpg GRAPHIC 56338
9 GRAPHIC g2018030720565444843904.jpg GRAPHIC 2469
  Complete submission text file 0001564590-18-004750.txt   9781709

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT xene-20171231.xml EX-101.INS 2058326
11 XBRL TAXONOMY EXTENSION SCHEMA xene-20171231.xsd EX-101.SCH 56506
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20171231_cal.xml EX-101.CAL 48520
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20171231_def.xml EX-101.DEF 179716
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20171231_lab.xml EX-101.LAB 440094
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20171231_pre.xml EX-101.PRE 350400
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36687 | Film No.: 18673948
SIC: 2834 Pharmaceutical Preparations